CONMED Corporation (CNMD)

Pretax margin

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Earnings before tax but after interest (EBT) (ttm) US$ in thousands 80,829 29,608 25,039 -85,863 -70,861 -30,675 -28,948 80,820 73,105 56,955 56,866 7,843 1,603 5,344 -2,562 36,672 31,224 34,279 31,143 36,236
Revenue (ttm) US$ in thousands 1,244,743 1,168,565 1,139,075 1,098,613 1,045,472 1,068,575 1,042,314 1,020,285 1,010,635 989,493 978,501 881,125 862,458 874,495 870,250 950,728 955,096 932,675 901,392 875,949
Pretax margin 6.49% 2.53% 2.20% -7.82% -6.78% -2.87% -2.78% 7.92% 7.23% 5.76% 5.81% 0.89% 0.19% 0.61% -0.29% 3.86% 3.27% 3.68% 3.45% 4.14%

December 31, 2023 calculation

Pretax margin = EBT (ttm) ÷ Revenue (ttm)
= $80,829K ÷ $1,244,743K
= 6.49%

Conmed Corp.'s pretax margin has varied significantly over the past eight quarters. In Q4 2023, the pretax margin improved to 6.49%, representing a notable increase from the previous quarter's 2.53%. However, in Q1 2023, the company reported a negative pretax margin of -7.82%, indicating a loss before taxes. This negative trend was also observed in Q4 2022, where the pretax margin was -6.78%.

On the positive side, there were periods of profitability, such as in Q1 2022 when the pretax margin reached 7.92%. Overall, Conmed Corp.'s pretax margin has shown volatility and inconsistency, suggesting fluctuations in its operating efficiency and profitability over the past two years. Further analysis is needed to understand the factors driving these fluctuations and to assess the company's ability to maintain sustainable profitability in the future.


Peer comparison

Dec 31, 2023